
Bruker Corporation is a medical devices business based in the US. Bruker Corporation shares (BRKR) are listed on the NASDAQ and all prices are listed in US Dollars. Bruker Corporation employs 8,525 staff and has a trailing 12-month revenue of around $2.5 billion.
How to buy Bruker Corporation stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BRKR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Bruker Corporation stock price (NASDAQ: BRKR)
Use our graph to track the performance of BRKR stocks over time.Bruker Corporation shares at a glance
Latest market close | $76.41 |
---|---|
52-week range | $48.35 - $76.75 |
50-day moving average | $71.88 |
200-day moving average | $64.42 |
Wall St. target price | $79.44 |
PE ratio | 36.5517 |
Dividend yield | $0.2 (0.27%) |
Earnings per share (TTM) | $2.03 |
Buy Bruker Corporation stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Bruker Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Bruker Corporation price performance over time
Historical closes compared with the close of $76.41 from 2023-03-27
1 week (2023-03-21) | 3.37% |
---|---|
1 month (2023-02-28) | 10.87% |
3 months (2022-12-28) | 15.13% |
6 months (2022-09-28) | 48.02% |
1 year (2022-03-24) | N/A |
---|---|
2 years (2021-03-26) | 20.59% |
3 years (2020-03-27) | 108.39% |
5 years (2018-03-28) | 162.02% |
Is Bruker Corporation stock undervalued or overvalued?
Valuing Bruker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bruker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Bruker Corporation financials
Revenue TTM | $2.5 billion |
---|---|
Operating margin TTM | 18.04% |
Gross profit TTM | $1.3 billion |
Return on assets TTM | 7.86% |
Return on equity TTM | 26.93% |
Profit margin | 11.72% |
Book value | $7.58 |
Market capitalisation | $10.9 billion |
TTM: trailing 12 months
Bruker Corporation share dividends
Dividend payout ratio: 8.55% of net profits
Recently Bruker Corporation has paid out, on average, around 8.55% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.27% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Bruker Corporation shareholders could enjoy a 0.27% return on their shares, in the form of dividend payments. In Bruker Corporation's case, that would currently equate to about $0.2 per share.
While Bruker Corporation's payout ratio might seem low, this can signify that Bruker Corporation is investing more in its future growth.
Bruker Corporation's most recent dividend payout was on 16 March 2023. The latest dividend was paid out to all shareholders who bought their shares by 27 February 2023 (the "ex-dividend date").
Bruker Corporation share price volatility
Over the last 12 months, Bruker Corporation's shares have ranged in value from as little as $48.3479 up to $76.7546. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Bruker Corporation's is 1.141. This would suggest that Bruker Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Bruker Corporation overview
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts. .
Bruker Corporation in the news
The 3 Most Promising Biotech Stocks to Buy Now
Bruker (BRKR) Receives 1.2 GHz NMR System Orders From the UK
Waters (WAT) Down 6.1% Since Last Earnings Report: Can It Rebound?
Frequently asked questions
What percentage of Bruker Corporation is owned by insiders or institutions?Currently 32.86% of Bruker Corporation shares are held by insiders and 71.853% by institutions. How many people work for Bruker Corporation?
Latest data suggests 8,525 work at Bruker Corporation. When does the fiscal year end for Bruker Corporation?
Bruker Corporation's fiscal year ends in December. Where is Bruker Corporation based?
Bruker Corporation's address is: 40 Manning Road, Billerica, MA, United States, 01821 What is Bruker Corporation's ISIN number?
Bruker Corporation's international securities identification number is: US1167941087 What is Bruker Corporation's CUSIP number?
Bruker Corporation's Committee on Uniform Securities Identification Procedures number is: 116795105
More guides on Finder
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
How to Buy Gold Stocks
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert